Adicet Bio, Inc. (ACET)
9.02
+0.75
(+9.07%)
USD |
NASDAQ |
Sep 25, 16:00
9.99
+0.97
(+10.75%)
After-Hours: 19:59
Adicet Bio Price to Book Value : 0.7029 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 0.7029 |
| September 24, 2026 | 0.6444 |
| September 23, 2026 | 0.6616 |
| September 22, 2026 | 0.7126 |
| September 21, 2026 | 0.6958 |
| September 18, 2026 | 0.7153 |
| September 17, 2026 | 0.7021 |
| September 16, 2026 | 0.7052 |
| September 15, 2026 | 0.6627 |
| September 14, 2026 | 0.7558 |
| September 11, 2026 | 0.7418 |
| September 10, 2026 | 0.7426 |
| September 09, 2026 | 0.7434 |
| September 08, 2026 | 0.7582 |
| September 04, 2026 | 0.7473 |
| September 03, 2026 | 0.7348 |
| September 02, 2026 | 0.7216 |
| September 01, 2026 | 0.7216 |
| August 31, 2026 | 0.6779 |
| August 28, 2026 | 0.706 |
| August 27, 2026 | 0.7021 |
| August 26, 2026 | 0.6974 |
| August 25, 2026 | 0.7013 |
| August 24, 2026 | 0.6935 |
| August 21, 2026 | 0.7161 |
| Date | Value |
|---|---|
| August 20, 2026 | 0.7309 |
| August 19, 2026 | 0.7395 |
| August 18, 2026 | 0.7099 |
| August 17, 2026 | 0.681 |
| August 14, 2026 | 0.653 |
| August 13, 2026 | 0.6436 |
| August 12, 2026 | 0.6436 |
| August 11, 2026 | 0.6413 |
| August 10, 2026 | 0.6319 |
| August 07, 2026 | 0.6218 |
| August 06, 2026 | 0.6179 |
| August 05, 2026 | 0.7138 |
| August 04, 2026 | 0.7177 |
| August 03, 2026 | 0.72 |
| July 31, 2026 | 0.7099 |
| July 30, 2026 | 0.706 |
| July 29, 2026 | 0.6468 |
| July 28, 2026 | 0.639 |
| July 27, 2026 | 0.6281 |
| July 24, 2026 | 0.607 |
| July 23, 2026 | 0.6561 |
| July 22, 2026 | 0.6678 |
| July 21, 2026 | 0.6327 |
| July 20, 2026 | 0.6148 |
| July 17, 2026 | 0.6327 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.724 |
| Alnylam Pharmaceuticals, Inc. | 25.28 |
| Anika Therapeutics, Inc. | 1.986 |
| Savara, Inc. | 7.149 |
| Vericel Corp. | 5.491 |
Price to Book Value Related Metrics
| PEG Ratio | -0.2541 |
| Price | 9.02 |
| Earnings Yield | -127.9% |
| Market Cap | 84.44M |
| PEGY Ratio | -0.2541 |